Voglistat 0.3mg Tablet
Marketer
Stature Life Sciences
Salt Composition
Voglibose (0.3mg)
Overview Voglistat 0.3mg Tablet
For individuals with type 2 diabetes, the 0.3mg Voglistat tablet aids in post-meal blood glucose regulation. Prescribed when dietary adjustments and other comparable medications prove insufficient, this medication is administered immediately before meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Abrupt cessation requires prior medical consultation to prevent potentially serious complications, including elevated blood glucose, kidney impairment, and vision loss. Successful treatment necessitates adherence to a comprehensive program incorporating dietary changes, regular exercise, and weight management, as directed by your doctor. Regular blood glucose monitoring is essential. Common side effects include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea; persistent or bothersome effects necessitate medical attention. While Voglistat itself doesn't induce hypoglycemia, concurrent use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. Treatment for resulting hypoglycemia requires plain glucose; table sugar is ineffective in this context. Prior to initiating treatment, disclose any kidney or liver conditions to your physician. Contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis), pregnant or breastfeeding women should seek medical advice before use. Complete disclosure of all other medications ensures safe usage. Excessive alcohol consumption should be avoided due to an increased hypoglycemia risk.
Primary Ingredients of Voglistat 0.3mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Voglistat 0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Voglistat 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 0.3mg Voglistat tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Voglistat 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglistat 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.3mg Voglistat tablet should be taken on an empty stomach.
How Voglistat 0.3mg Tablet works:
Voglistat 0.3mg tablets are used to manage diabetes. They function by blocking intestinal enzymes that digest complex carbohydrates into simpler sugars like glucose, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglistat 0.3mg Tablet and alcohol is inadvisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglistat 0.3mg tablets is generally deemed safe. Animal research indicates minimal or no negative consequences for fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglistat 0.3mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglistat 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglistat 0.3mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglistat 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Voglistat 0.3mg Tablet :
Omit any missed Voglistat 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglistat 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |



